ATE383863T1 - Kombinationschemotherapie - Google Patents

Kombinationschemotherapie

Info

Publication number: ATE383863T1
Authority: AT; Austria
Prior art keywords: vitamin; derivative; administering; patient; cell
Prior art date: 2000-03-02

Application number

AT01916350T

Other languages

English (en)

Inventor

Candace Johnson

Donald Trump

Original Assignee

Univ Pittsburgh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-02

Filing date

2001-03-02

Publication date

2008-02-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27392114&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE383863(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-04-06 Priority claimed from US09/544,724 external-priority patent/US6559139B1/en

2001-03-02 Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh

2008-02-15 Application granted granted Critical

2008-02-15 Publication of ATE383863T1 publication Critical patent/ATE383863T1/de

Links

238000009096 combination chemotherapy Methods 0.000 title abstract 2
229930003316 Vitamin D Natural products 0.000 abstract 5
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 5
235000019166 vitamin D Nutrition 0.000 abstract 5
239000011710 vitamin D Substances 0.000 abstract 5
150000003710 vitamin D derivatives Chemical class 0.000 abstract 5
229940046008 vitamin d Drugs 0.000 abstract 5
238000000034 method Methods 0.000 abstract 4
206010028980 Neoplasm Diseases 0.000 abstract 3
229940127089 cytotoxic agent Drugs 0.000 abstract 2
239000002254 cytotoxic agent Substances 0.000 abstract 2
231100000599 cytotoxic agent Toxicity 0.000 abstract 2
206010060862 Prostate cancer Diseases 0.000 abstract 1
208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
150000004347 all-trans-retinol derivatives Chemical class 0.000 abstract 1
238000011260 co-administration Methods 0.000 abstract 1
239000003862 glucocorticoid Substances 0.000 abstract 1
230000000979 retarding effect Effects 0.000 abstract 1
XRASPMIURGNCCH-UHFFFAOYSA-N zoledronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CN1C=CN=C1 XRASPMIURGNCCH-UHFFFAOYSA-N 0.000 abstract 1
229960004276 zoledronic acid Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Seasonings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT01916350T 2000-03-02 2001-03-02 Kombinationschemotherapie ATE383863T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US18650600P	2000-03-02	2000-03-02
US18780600P	2000-03-08	2000-03-08
US09/544,724 US6559139B1 (en)	1997-08-29	2000-04-06	Combination chemotherapy

Publications (1)

Publication Number	Publication Date
ATE383863T1 true ATE383863T1 (de)	2008-02-15

Family

ID=27392114

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01916350T ATE383863T1 (de)	2000-03-02	2001-03-02	Kombinationschemotherapie

Country Status (8)

Country	Link
EP (1)	EP1276482B1 (de)
JP (1)	JP2003525254A (de)
AT (1)	ATE383863T1 (de)
AU (4)	AU4338501A (de)
CA (1)	CA2401304A1 (de)
DK (1)	DK1276482T3 (de)
ES (1)	ES2300323T3 (de)
WO (1)	WO2001064251A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6538037B2 (en)	1991-01-08	2003-03-25	Bone Care International, Inc.	Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6573256B2 (en)	1996-12-30	2003-06-03	Bone Care International, Inc.	Method of inhibiting angiogenesis using active vitamin D analogues
US6503893B2 (en) *	1996-12-30	2003-01-07	Bone Care International, Inc.	Method of treating hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en)	1996-12-30	2003-05-20	Bone Care International, Inc.	Method of treating malignancy associated hypercalcemia using active vitamin D analogues
EP1064000B1 (de)	1998-03-27	2011-07-06	Oregon Health & Science University	Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
JP4502641B2 (ja) *	2002-01-24	2010-07-14	ティルタンファーマリミテッド	抗癌組み合わせおよびその使用方法
US20050043233A1 (en) *	2003-04-29	2005-02-24	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
US7094775B2 (en)	2004-06-30	2006-08-22	Bone Care International, Llc	Method of treating breast cancer using a combination of vitamin D analogues and other agents
HRP20130961T1 (hr) *	2006-08-25	2013-11-22	Janssen Oncology, Inc.	Kombinacije za tretman raka
CA2838089A1 (en) *	2006-08-25	2008-02-28	Cougar Biotechnology, Inc.	Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
US20080051380A1 (en)	2006-08-25	2008-02-28	Auerbach Alan H	Methods and compositions for treating cancer
SG2014006324A (en) *	2009-01-27	2014-03-28	Berg Llc	Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
MX2019001224A (es)	2016-07-29	2019-06-03	Janssen Pharmaceutica Nv	Metodos para tratar el cancer de prostata.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5602116A (en) *	1988-08-02	1997-02-11	Bone Care International, Inc.	Method for treating and preventing secondary hyperparathyroidism
US5616571A (en) *	1995-06-06	1997-04-01	Merck & Co., Inc.	Bisphosphonates prevent bone loss associated with immunosuppressive therapy
US5900429A (en) *	1997-01-28	1999-05-04	The Procter & Gamble Company	Method for inhibiting the growth of cancers
US6087350A (en) *	1997-08-29	2000-07-11	University Of Pittsburgh Of The Commonwealth System Of Higher Education	Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
EP1064000B1 (de) *	1998-03-27	2011-07-06	Oregon Health & Science University	Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen

2001
- 2001-03-02 EP EP01916350A patent/EP1276482B1/de not_active Revoked
- 2001-03-02 WO PCT/US2001/006748 patent/WO2001064251A2/en not_active Ceased
- 2001-03-02 AT AT01916350T patent/ATE383863T1/de not_active IP Right Cessation
- 2001-03-02 ES ES01916350T patent/ES2300323T3/es not_active Expired - Lifetime
- 2001-03-02 AU AU4338501A patent/AU4338501A/xx active Pending
- 2001-03-02 JP JP2001563148A patent/JP2003525254A/ja active Pending
- 2001-03-02 AU AU2001243385A patent/AU2001243385B2/en not_active Ceased
- 2001-03-02 CA CA002401304A patent/CA2401304A1/en not_active Abandoned
- 2001-03-02 DK DK01916350T patent/DK1276482T3/da active
2007
- 2007-02-01 AU AU2007200423A patent/AU2007200423B2/en not_active Ceased
2010
- 2010-01-04 AU AU2010200000A patent/AU2010200000A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2003525254A (ja)	2003-08-26
DK1276482T3 (da)	2008-05-26
AU2010200000A1 (en)	2010-01-28
CA2401304A1 (en)	2001-09-07
AU4338501A (en)	2001-09-12
WO2001064251A2 (en)	2001-09-07
AU2007200423B2 (en)	2009-10-01
AU2001243385B2 (en)	2006-11-02
EP1276482A2 (de)	2003-01-22
ES2300323T3 (es)	2008-06-16
EP1276482B1 (de)	2008-01-16
AU2007200423A1 (en)	2007-02-22
WO2001064251A3 (en)	2002-05-10

Similar Documents

Publication	Publication Date	Title
BR0209147A (pt)	2004-06-08	Terapia combinada que usa anticorpos anti-egfr e agentes anti-hormonais
ATE383863T1 (de)	2008-02-15	Kombinationschemotherapie
NZ336511A (en)	2001-08-31	Treating prostatic diseases using delayed and/or sustained release formulations of activated vitamin D
CY1116463T1 (el)	2017-03-15	Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
DK1169059T3 (da)	2006-02-27	Docetaxel i kombination med rhuMAb HER2 til behandling af cancere
DE60026538D1 (de)	2006-05-04	Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
DK1030670T3 (da)	2004-10-04	Anvendelse af vitamin D-derivater til forstærkning af virkningen af cytotoksiske midler
WO2001030802A3 (en)	2002-02-14	Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
TW200500355A (en)	2005-01-01	Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
EA200001043A2 (ru)	2001-12-24	Соединения для лечения женской сексуальной дисфункции
DE60112102D1 (de)	2005-08-25	Kombination aus einem no-donor und einem antioxidans zur behanndlung sexueller störungen
IS6558A (is)	2002-09-20	Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
DE69817602D1 (de)	2003-10-02	Arzneistoffverabreichungssystem mit zweistufigem targeting
WO2004110151A8 (en)	2005-03-03	Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
BRPI0413410A (pt)	2006-10-10	co-administração de um polissacarìdeo com um agente quimioterapêutico para o tratamento de cáncer
AU2003244762A1 (en)	2003-12-19	Methods and compositions for intravesical therapy of bladder cancer
DE59911734D1 (de)	2005-04-14	Kombination von selen-haltigen verbindungen mit gemcitabin oder mitomycin c
WO2005117542A3 (en)	2006-04-20	Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments
WO2004007676A3 (en)	2004-04-08	Combination therapy for the treatment of neoplasms
AU2001272017A1 (en)	2002-01-02	Targeted combination immunotherapy of cancer and infectious diseases
WO2001041747A3 (de)	2002-02-07	Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs
CY1107256T1 (el)	2012-11-21	Χημειοθεραπεια συνδυασμου
MXPA03006359A (es)	2004-04-20	Metodo para tratamiento del cancer.
EP1374873B8 (de)	2005-06-29	Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie
MX2025001881A (es)	2025-04-02	Terapia que comprende anticuerpos anti cumulo de diferenciacion 19 (cd19) y moduladores del homologo 2 del potenciador de la proteina zeste (ezh2)

Legal Events

Date

Code

Title

Description

2008-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1276482

Country of ref document: EP

2010-12-15

REN

Ceased due to non-payment of the annual fee

2011-05-15

RZN

Patent revoked